Genetic Technologies Grants License to Genzyme for Human Genetic Testing Applications
The license granted by GTG to Genzyme covers a wide range of human genetic testing applications -- including research, pre-clinical trials and commercial genetic testing. These rights will apply non-exclusively in USA, Europe and Japan. GTG retains the rights to these tests in the Asia-Pacific region, where the Company continues to build its own genetic testing capability.
Commenting on the agreement, Dr. Mervyn Jacobson, executive chairman of Genetic Technologies, said, "We are delighted to extend rights to this important intellectual property to a company of Genzyme's stature. This agreement is a significant step as we continue to license rights worldwide."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.